Evidencia pura y dura y sin ningún conflicto de interés ya que tenemos la libertad de no tener ningún grupo empresarial que nos sesgue, te traemos el capítulo de tratamiento de la Diabetes Mellitus tipo 2, desde lo no farmacológico hasta la ruta farmacológica y sus pasos.

Recomendamos una pasada por nuestros capítulos previos y esperamos que lo disfrutes como nosotros lo hacemos haciendo éste contenido

Síguenos en IG, Twitter y Youtube como @PodMedicos.

Fuentes:
[1]American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee:, Draznin B, Aroda VR, Bakris G, Benson G, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S125–43.
[2]Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, et al. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med 2016;164:740–51.
[3]Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. JAMA 2016;316:313–24.
[4]Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018;41:2669–701.
[5]American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee:, Draznin B, Aroda VR, Bakris G, Benson G, et al. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S144–74.


Música: Bensound.com
Arte: Daniela Sofia Castañeda™